Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SCPS

Scopus BioPharma (SCPS)

Scopus BioPharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SCPS
DateTimeSourceHeadlineSymbolCompany
03/11/202300:15GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
29/06/202307:16Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:SCPSScopus BioPharma Inc
13/05/202307:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
29/04/202307:05Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SCPSScopus BioPharma Inc
15/04/202307:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCPSScopus BioPharma Inc
16/12/202222:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
03/12/202209:17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SCPSScopus BioPharma Inc
22/11/202209:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
16/11/202209:16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SCPSScopus BioPharma Inc
11/11/202201:15GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
19/10/202200:25GlobeNewswire Inc.Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder ValueNASDAQ:SCPSScopus BioPharma Inc
03/09/202207:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
28/05/202207:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
20/05/202207:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
14/05/202207:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
05/05/202222:30GlobeNewswire Inc.Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of DirectorsNASDAQ:SCPSScopus BioPharma Inc
05/05/202207:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
03/05/202206:47Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SCPSScopus BioPharma Inc
30/04/202207:38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
16/04/202206:18Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCPSScopus BioPharma Inc
09/04/202207:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
02/04/202208:17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:SCPSScopus BioPharma Inc
25/03/202208:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
23/03/202221:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
23/03/202211:30GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies SummitNASDAQ:SCPSScopus BioPharma Inc
05/03/202209:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
19/02/202209:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
21/01/202209:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
21/01/202200:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:SCPSScopus BioPharma Inc
19/01/202222:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SCPSScopus BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:SCPS